Home » J&J Mulls Diagnostic Unit Sale, Expects Product Launches in 2013
J&J Mulls Diagnostic Unit Sale, Expects Product Launches in 2013
Disappointing fourth quarter diagnostic sales and strong competition from companies like Abbott, Roche and Siemens have Johnson & Johnson eyeing a future without its $2.2 billion Ortho Clinical Diagnostics (OCD) business.
Devices & Diagnostics Letter
Devices & Diagnostics Letter
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May